Serial Number
76221925
Owner
MOUNTAIN VIEW PHARMACEUTICALS, INC.First Use Date
Feb 5, 2004
Filing Date
Mar 8, 2001
PHARMAPEG Trademark
Serial Number: 76221925 • Registration: 3029593
Trademark Classes
Class 1 - Chemicals
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Class 5 - Pharmaceuticals
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Class 42 - Computer & Scientific
Scientific and technological services; industrial analysis and research services
Class 35 - Advertising & Business
Advertising; business management; business administration; office functions
Owner Contact Info
3475-S Edison Way
Menlo Park, CA 940251813
Entity Type: 03
Trademark Details
Filing Date
March 8, 2001
Registration Date
December 13, 2005
First Use Anywhere
February 5, 2004
First Use in Commerce
February 5, 2004
Published for Opposition
July 9, 2002
Goods & Services
[ diagnostic reagents for clinical or medical laboratory use; contrasting agent for ultrasound diagnostic imaging; cells for medical or clinical use; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for use in gene therapy; pharmaceutical preparations for inhalation therapy; and vaccines ]
licensing of technology in the fields of pharmaceuticals, veterinary products, sanitary products, gene therapy and inhalation therapy
[ chemical additives for use in the manufacture of pharmaceutical and cosmetic preparations and substances; diagnostic reagents for scientific or research use; cells for scientific, laboratory, or medical research; and coatings used in the manufacture of medical devices to enhance biocompatibility ]
technical consultation and research in the field of pharmaceuticals, veterinary products, sanitary products, gene therapy, cancer treatment, therapies for metabolic diseases, and polymer technology; development of new technology for others in the field of pharmaceuticals, veterinary products, sanitary products, gene therapy, cancer treatment, therapies for metabolic diseases, and polymer technology
